10122-210 : Myalept 11.3 mg/2.2ml Subcutaneous Injection, Powder, Lyophilized, for Solution


NDC: 10122-210
Labeler: Chiesi USA, Inc.
Product Type: Human Prescription Drug
Drug Name:  Myalept
Dosage Form: Subcutaneous Injection, Powder, Lyophilized, for Solution
Application #: BLA125390
Rev. Date: 


NDC Package Codes:

  • 10122-210-02: 1 VIAL, GLASS IN 1 CARTON (10122‑210‑02) / 2.2 ML IN 1 VIAL, GLASS

Active Ingredients:

  • Metreleptin

Dosage Strength:

  • 11.3 mg/2.2mL

Pharmaceutical Classes:

  • Analogs/Derivatives [Chemical/Ingredient]
  • Leptin Analog [EPC]
  • Leptin [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 66780-310 Myalept 11.3 mg/2.2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Amylin Pharmaceuticals, LLC
  • 76431-210 Myalept 11.3 mg/2.2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Aegerion Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 10122-210 QR Code

< Prev: 10122-180Next: 10122-212 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.